S&P 500   4,198.28 (+0.44%)
DOW   32,929.01 (+0.06%)
QQQ   348.33 (+0.10%)
AAPL   178.44 (+0.67%)
MSFT   327.42 (-0.30%)
META   270.58 (+2.21%)
GOOGL   123.07 (+0.16%)
AMZN   121.08 (+0.41%)
TSLA   202.27 (-0.81%)
NVDA   388.67 (+2.73%)
NIO   7.31 (-2.92%)
BABA   81.96 (+3.03%)
AMD   117.60 (-0.52%)
T   15.74 (+0.06%)
F   12.01 (+0.08%)
MU   68.50 (+0.44%)
CGC   0.84 (+0.59%)
GE   103.33 (+1.77%)
DIS   88.11 (+0.17%)
AMC   4.61 (+2.44%)
PFE   38.13 (+0.29%)
PYPL   62.75 (+1.23%)
NFLX   399.99 (+1.20%)
S&P 500   4,198.28 (+0.44%)
DOW   32,929.01 (+0.06%)
QQQ   348.33 (+0.10%)
AAPL   178.44 (+0.67%)
MSFT   327.42 (-0.30%)
META   270.58 (+2.21%)
GOOGL   123.07 (+0.16%)
AMZN   121.08 (+0.41%)
TSLA   202.27 (-0.81%)
NVDA   388.67 (+2.73%)
NIO   7.31 (-2.92%)
BABA   81.96 (+3.03%)
AMD   117.60 (-0.52%)
T   15.74 (+0.06%)
F   12.01 (+0.08%)
MU   68.50 (+0.44%)
CGC   0.84 (+0.59%)
GE   103.33 (+1.77%)
DIS   88.11 (+0.17%)
AMC   4.61 (+2.44%)
PFE   38.13 (+0.29%)
PYPL   62.75 (+1.23%)
NFLX   399.99 (+1.20%)
S&P 500   4,198.28 (+0.44%)
DOW   32,929.01 (+0.06%)
QQQ   348.33 (+0.10%)
AAPL   178.44 (+0.67%)
MSFT   327.42 (-0.30%)
META   270.58 (+2.21%)
GOOGL   123.07 (+0.16%)
AMZN   121.08 (+0.41%)
TSLA   202.27 (-0.81%)
NVDA   388.67 (+2.73%)
NIO   7.31 (-2.92%)
BABA   81.96 (+3.03%)
AMD   117.60 (-0.52%)
T   15.74 (+0.06%)
F   12.01 (+0.08%)
MU   68.50 (+0.44%)
CGC   0.84 (+0.59%)
GE   103.33 (+1.77%)
DIS   88.11 (+0.17%)
AMC   4.61 (+2.44%)
PFE   38.13 (+0.29%)
PYPL   62.75 (+1.23%)
NFLX   399.99 (+1.20%)
S&P 500   4,198.28 (+0.44%)
DOW   32,929.01 (+0.06%)
QQQ   348.33 (+0.10%)
AAPL   178.44 (+0.67%)
MSFT   327.42 (-0.30%)
META   270.58 (+2.21%)
GOOGL   123.07 (+0.16%)
AMZN   121.08 (+0.41%)
TSLA   202.27 (-0.81%)
NVDA   388.67 (+2.73%)
NIO   7.31 (-2.92%)
BABA   81.96 (+3.03%)
AMD   117.60 (-0.52%)
T   15.74 (+0.06%)
F   12.01 (+0.08%)
MU   68.50 (+0.44%)
CGC   0.84 (+0.59%)
GE   103.33 (+1.77%)
DIS   88.11 (+0.17%)
AMC   4.61 (+2.44%)
PFE   38.13 (+0.29%)
PYPL   62.75 (+1.23%)
NFLX   399.99 (+1.20%)
NASDAQ:VERU

Veru (VERU) News Today

$1.01
+0.02 (+2.02%)
(As of 10:40 AM ET)
Compare
Today's Range
$0.96
$1.02
50-Day Range
$0.99
$1.49
52-Week Range
$0.93
$24.55
Volume
871,674 shs
Average Volume
2.53 million shs
Market Capitalization
$90.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.



VERU Media Mentions By Week

VERU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VERU
News Sentiment

0.00

0.66

Average
Medical
News Sentiment

VERU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VERU Articles
This Week

0

5

VERU Articles
Average Week

SourceHeadline
finance.yahoo.com logoVeru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Board
finance.yahoo.com - June 1 at 9:53 AM
finance.yahoo.com logoVeru to Present at the Jefferies Healthcare Conference
finance.yahoo.com - May 24 at 8:58 AM
MarketBeat logoHC Wainwright Equities Analysts Decrease Earnings Estimates for Veru Inc. (NASDAQ:VERU)
americanbankingnews.com - May 20 at 2:58 AM
msn.com logoHC Wainwright & Co. Maintains Veru (VERU) Buy Recommendation
msn.com - May 15 at 4:58 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Veru (VERU)
markets.businessinsider.com - May 15 at 8:36 AM
MarketBeat logoVeru (NASDAQ:VERU) PT Lowered to $2.00
americanbankingnews.com - May 15 at 7:56 AM
finanznachrichten.de logoVeru Inc.: Veru Reports Fiscal 2023 Second Quarter Financial Results
finanznachrichten.de - May 12 at 8:49 PM
msn.com logoVeru Q2: Revenue Halves, Prioritizes Clinical Programs, Wider Loss & More
msn.com - May 12 at 10:49 AM
finance.yahoo.com logoVeru Inc. (VERU) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - May 11 at 1:35 PM
msn.com logoVeru: Q2 Earnings Insights
msn.com - May 11 at 8:34 AM
markets.businessinsider.com logoVERU Stock Earnings: Veru Misses EPS, Beats Revenue Estimates
markets.businessinsider.com - May 11 at 8:34 AM
finance.yahoo.com logoVeru Reports Fiscal 2023 Second Quarter Financial Results
finance.yahoo.com - May 11 at 8:34 AM
markets.businessinsider.com logoAnalyst Ratings for Veru
markets.businessinsider.com - May 10 at 3:55 PM
msn.com logoA Preview Of Veru's Earnings
msn.com - May 10 at 3:55 PM
msn.com logoVeru Q2 2023 Earnings Preview
msn.com - May 10 at 3:55 PM
finance.yahoo.com logoIs a Surprise Coming for Veru (VERU) This Earnings Season?
finance.yahoo.com - May 9 at 3:10 PM
MarketBeat logoVeru (VERU) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - May 9 at 4:34 AM
finance.yahoo.com logoVeru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDS
finance.yahoo.com - May 4 at 1:26 PM
finance.yahoo.com logoVeru Inc. (VERU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - May 4 at 1:26 PM
marketbeat.com logoVeru (VERU) to Release Quarterly Earnings on Thursday
marketbeat.com - May 4 at 2:25 AM
finance.yahoo.com logoVeru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital
finance.yahoo.com - May 3 at 10:58 AM
MarketBeat logoQ2 2023 Earnings Estimate for Veru Inc. (NASDAQ:VERU) Issued By HC Wainwright
americanbankingnews.com - April 30 at 1:44 AM
MarketBeat logoVeru Inc. (NASDAQ:VERU) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - April 29 at 5:08 AM
marketbeat.com logoVeru Inc. (NASDAQ:VERU) Short Interest Update
marketbeat.com - April 28 at 9:50 AM
marketbeat.com logoQ2 2023 EPS Estimates for Veru Inc. Reduced by HC Wainwright (NASDAQ:VERU)
marketbeat.com - April 28 at 6:40 AM
finance.yahoo.com logoVeru to Report Fiscal 2023 Second Quarter Financial Results on May 11, 2023
finance.yahoo.com - April 27 at 9:44 AM
finance.yahoo.com logoVeru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones
finance.yahoo.com - April 20 at 9:08 AM
finance.yahoo.com logoVeru Enters Into Supply Agreement with Afaxys to Expand Access to FC2 Female Condom® in U.S. Public Health Sector
finance.yahoo.com - April 19 at 1:28 PM
MarketBeat logoVeru (NASDAQ:VERU) Receives Buy Rating from HC Wainwright
americanbankingnews.com - April 15 at 3:16 AM
markets.businessinsider.com logoThe Latest Analyst Ratings for Veru
markets.businessinsider.com - April 13 at 4:38 PM
msn.com logoHC Wainwright & Co. Reiterates Veru (VERU) Buy Recommendation
msn.com - April 13 at 4:38 PM
finance.yahoo.com logoDown -51.21% in 4 Weeks, Here's Why You Should You Buy the Dip in Veru Inc. (VERU)
finance.yahoo.com - April 12 at 1:37 PM
finance.yahoo.com logoOnce COVID-19 Candidate, Veru's Sabizabulin Shows Encouraging Action In Animal Studies Against Poxvirus
finance.yahoo.com - April 11 at 8:32 PM
finance.yahoo.com logoVeru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
finance.yahoo.com - April 11 at 10:31 AM
MarketBeat logoVeru (NASDAQ:VERU) Given New $6.00 Price Target at HC Wainwright
americanbankingnews.com - April 7 at 7:28 AM
MarketBeat logoVeru Inc. (NASDAQ:VERU) Receives $28.33 Average Target Price from Analysts
americanbankingnews.com - April 7 at 3:30 AM
finance.yahoo.com logoVeru Announces Preclinical Results from Expanded Sabizabulin Program into Influenza-Induced Severe Acute Respiratory Distress Syndrome and Provides Update on COVID-19 Program
finance.yahoo.com - April 4 at 1:31 PM
finance.yahoo.com logoVeru Inc.'s (NASDAQ:VERU) recent 20% pullback adds to one-year year losses, institutional owners may take drastic measures
finance.yahoo.com - March 27 at 8:25 AM
marketbeat.com logoOppenheimer Weighs in on Veru Inc.'s Q2 2023 Earnings (NASDAQ:VERU)
marketbeat.com - March 17 at 6:20 AM
finance.yahoo.com logoUPDATE 1-Veru to proceed with late-stage study of COVID pill despite FDA snub
finance.yahoo.com - March 14 at 5:52 PM
marketbeat.com logo407,139 Shares in Veru Inc. (NASDAQ:VERU) Acquired by Renaissance Technologies LLC
marketbeat.com - March 13 at 4:35 AM
marketbeat.com logoVeru Inc. (NASDAQ:VERU) Given Consensus Recommendation of "Buy" by Brokerages
marketbeat.com - March 10 at 4:43 AM
finance.yahoo.com logoVeru to Present at the Oppenheimer 33rd Annual Healthcare Conference
finance.yahoo.com - March 7 at 9:18 AM
investorplace.com logoWhy Is Veru (VERU) Stock Down 37% Today?
investorplace.com - March 3 at 11:00 AM
finance.yahoo.com logoVeru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS
finance.yahoo.com - March 2 at 6:59 PM
finance.yahoo.com logoVeru Inc. (NASDAQ:VERU) Shares Could Be 50% Below Their Intrinsic Value Estimate
finance.yahoo.com - February 14 at 10:09 AM
marketbeat.com logoVeru Inc. (NASDAQ:VERU) Expected to Post Q1 2024 Earnings of ($0.13) Per Share
marketbeat.com - February 13 at 3:06 AM
finance.yahoo.com logoVeru Inc. (NASDAQ:VERU) Q1 2023 Earnings Call Transcript
finance.yahoo.com - February 10 at 8:09 PM
marketbeat.com logoVeru (NASDAQ:VERU) Price Target Cut to $14.00 by Analysts at HC Wainwright
marketbeat.com - February 10 at 8:38 AM
benzinga.com logoFinal Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Veru Inc. (VERU) Investors of Class Action and to Actively Participate
benzinga.com - February 7 at 4:38 AM
Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VERU) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -